Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Mar 19, 2019
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2019-03-15$6.43/sh−417$2,681→ 10,832 total
Footnotes (1)
- [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.